443 results on '"He, Qiaojun"'
Search Results
2. Macrophage senescence in health and diseases
3. Insights into the role of derailed endocytic trafficking pathway in cancer: From the perspective of cancer hallmarks
4. Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4/MMP11 signalling axis
5. Unraveling the treatment effects of huanglian jiedu decoction on drug-induced liver injury based on network pharmacology, molecular docking and experimental validation
6. Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity
7. The palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML
8. Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
9. Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
10. Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
11. Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
12. Butein suppresses PD-L1 expression via downregulating STAT1 in non-small cell lung cancer
13. Structures of the endogenous peptide- and selective non-peptide agonist-bound SSTR2 signaling complexes
14. Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL
15. CovEpiAb: a comprehensive database and analysis resource for immune epitopes and antibodies of human coronaviruses
16. CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
17. Design, synthesis and biological evaluation of new dihydropyridine derivatives as PD-L1 degraders for enhancing antitumor immunity
18. Design, synthesis, and biological evaluation of quinazoline derivatives with covalent reversible warheads as potential FGFR4 inhibitors
19. Bisdemethoxycurcumin alleviates vandetanib-induced cutaneous toxicity in vivo and in vitro through autophagy activation
20. Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
21. SynergyX: a multi-modality mutual attention network for interpretable drug synergy prediction
22. Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy
23. Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling
24. Optineurin modulates the maturation of dendritic cells to regulate autoimmunity through JAK2-STAT3 signaling
25. ASFP (Artificial Intelligence based Scoring Function Platform): a web server for the development of customized scoring functions
26. Protective effect of borneol on the cutaneous toxicity of gilteritinib
27. Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ [Acta Pharmaceutica Sinica B 13 (2023) 2585–2600]
28. Deubiquitinating enzyme JOSD2 affects susceptibility of non-small cell lung carcinoma cells to anti-cancer drugs through DNA damage repair
29. s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand–foot skin reaction that can be reversed by nicotinamide
30. STAT3 dictates β-cell apoptosis by modulating PTEN in streptozocin-induced hyperglycemia
31. KLF12 transcriptionally regulates PD‐L1 expression in non‐small cell lung cancer.
32. TransFoxMol: predicting molecular property with focused attention
33. Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL
34. Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2
35. Palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML
36. Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
37. AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells
38. The impact of lipids on the cancer–immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy
39. Commentary: Deubiquitination complex platform: a plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
40. DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase
41. Correction: Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization
42. Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment
43. PTX3 from vascular endothelial cells contributes to trastuzumab-induced cardiac complications
44. Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review
45. Diosmetin protects against retinal injury via reduction of DNA damage and oxidative stress
46. Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver disease
47. PROTAC-DB 2.0: an updated database of PROTACs
48. IL-2K35C-moFA, a Long-Acting Engineered Cytokine with Decreased Interleukin 2 Receptor α Binding, Improved the Cellular Selectivity Profile and Antitumor Efficacy in a Mouse Tumor Model
49. Identification and Validation of Two Heterogeneous Molecular Subtypes and a Prognosis Predictive Model for Hepatocellular Carcinoma Based on Pyroptosis
50. The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.